We are the largest newborn pilot screening program in the United States. Our goal is to identify babies with rare disorders earlier #2025NBS#rarediseases
Excited to announce that ScreenPlus has another published paper out! Our marker paper gives you a great detailed overview of what we do! Congrats and thank you to everyone involved! doi.org/10.1016/j.ymgmr.2023…
Is someone you love living with the effects of Niemann-Pick disease? NNPDF is dedicated to supporting families every step of the way with programs, resources, and advocacy. Learn more about our work or make a donation at nnpdf.org/
Excited and proud to announce that we have officially enrolled over 35,000 babies into our study! Incredible work and huge thanks to all of our recruiters and to all involved in this project!
#RareDisease#newbornscreening
For rare diseases like #GM1 gangliosidosis, #research focusing on early detection and treatment can improve outcomes. 🧬
Check out the link below ⬇️ for more info on current clinical trials:
clinicaltrials.gov/search?co…
There are also less severe forms of #GM1 gangliosidosis that progress more slowly. For more information about #GM1, check out this link:
medlineplus.gov/genetics/con…
This month we’re spreading #awareness about #GM1 gangliosidosis, one of the rare conditions on our ScreenPlus panel.
Throughout the month, we’ll share some information and helpful resources, so follow along!
#newbornscreening#RareDisease